对于个性化再生医学而言iPSCs chondrogenic分化:文献综述
Eltahir Abdelrazig Mohamed Ali1,2, Rana Smaida3, Morgane Meyer2,3
1Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1260, Regenerative NanoMedicine (RNM), 1 Rue Eugène Boeckel, 67000, Strasbourg, France.
Stem cell research & therapy
|June 26, 2024
概括
诱导多能干细胞 (iPSCs) 提供了一种有前途的方法来产生软骨细胞来治疗软骨缺陷. 优化差异化和整合先进技术可以增强再生医学用于软骨修复的应用.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 生物技术是生物技术.
背景情况:
- 由于磨损,撕裂或创伤造成的软骨缺陷可能导致严重的关节病理.
- 软骨损伤通过减少缓冲和增加摩擦而损害关节功能.
- 目前用于软骨缺陷的治疗方法在有效性和侵入性方面存在局限性.
研究的目的:
- 对诱导多能干细胞 (iPSCs) 的体外冠状元分化的当前策略进行审查.
- 在疾病建模,药物查和再生医学中探索iPSC衍生型冠状细胞的应用.
- 讨论基于iPSC的软骨疗法的临床转化所需的进展.
主要方法:
- 审查现有的关于iPSC软体生成协议的文献.
- 分析优化细胞培养条件,生长因子和时间控制的技术.
- 探索新兴技术,如基因组编辑,有机体和3D生物打印.
主要成果:
- iPSCs可以分化为软骨细胞,为软骨修复提供潜在的来源.
- 优化的分化协议对于产生丰富的功能性肌肉细胞至关重要.
- 先进的技术是提高iPSC衍生性冠状细胞的翻译潜力的关键.
结论:
- 来自iPSC的软骨细胞代表了对软骨损伤和疾病的非侵入性治疗的有希望的途径.
- 临床应用需要在分化方法和制造系统方面取得进一步的进步.
- 自动化细胞疗法制造可以提高基于iPSC的软体生成的可扩展性,效率和安全性.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Induced Pluripotent Stem Cells
22.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.4K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


